Drug Shortage Report for ANORO ELLIPTA
| Report ID | 73358 |
| Drug Identification Number | 02418401 |
| Brand name | ANORO ELLIPTA |
| Common or Proper name | umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | Vilanterol Umeclidinium |
| Strength(s) | 25MCG 62.5MCG |
| Dosage form(s) | POWDER |
| Route of administration | INHALATION |
| Packaging size | 1x7 |
| ATC code | R03AL |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-01-18 |
| Estimated end date | 2019-02-15 |
| Actual end date | 2019-02-07 |
| Shortage status | Resolved |
| Updated date | 2019-02-08 |
| Company comments | 30 dose format is available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2019-02-08 | English | Compare |
| v2 | 2019-01-23 | French | Compare |
| v1 | 2019-01-23 | English | Compare |
Showing 1 to 3 of 3